Riediger, A. L., Dietz, S., Schirmer, U., Meister, M., Heinzmann-Groth, I., Schneider, M., . . . Sültmann, H. (2016). Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients. Sci Rep.
Citação norma ChicagoRiediger, Anja Lisa, Steffen Dietz, Uwe Schirmer, Michael Meister, Ingrid Heinzmann-Groth, Marc Schneider, Thomas Muley, Michael Thomas, and Holger Sültmann. "Mutation Analysis of Circulating Plasma DNA to Determine Response to EGFR Tyrosine Kinase Inhibitor Therapy of Lung Adenocarcinoma Patients." Sci Rep 2016.
MLA citiranjeRiediger, Anja Lisa, et al. "Mutation Analysis of Circulating Plasma DNA to Determine Response to EGFR Tyrosine Kinase Inhibitor Therapy of Lung Adenocarcinoma Patients." Sci Rep 2016.